Inari is a cutting-edge agricultural technology company that focuses on predictive design and advanced multiplex gene editing to develop sustainable and high-yielding crop varieties. The company has a well-defined commercial strategy with unique relationships with Independent Seed Companies and strategic partnerships with leading seed companies. Inari's product pipeline aims to bring about sustainability impact, efficiency improvements, and yield increase in the world's largest crop types.

John Casey

David Berry

Ignacio Martinez

Inari

CRISPR Biotech Engineering is an early-stage genome editing company that is committed to using innovative CRISPR-Cas9 technology to improve human lives.

CRISPR Biotech Engineering

Innoterra enables the agri-food ecosystem through digital connectivity, connecting Indian retailers and buyers with global farmers and sellers transparently and fairly. It offers tech-based solutions for various agricultural sectors, including dairy, food products, and bioscience.

Innoterra

Inari is the SEEDesign™ company, using new breeding technology to push the boundaries of what is possible by designing nature-positive seeds for a more sustainable global food system. A combination of AI-powered predictive design and a pioneered multiplex gene editing toolbox enables us to unlock the full potential of seed and advance critical solutions with broad applications for growing more food with fewer resources.

K2 HealthVentures

50 South Capital

Acre Venture Partners

EDBI

Flagship Pioneering

G Squared

Investment Corporation of Dubai (ICD)

Rivas Capital

Alexandria Venture Investments

Pavilion Capital

Pictet Private Equity Investors S.A.

Hanwha Impact Partners

Ischyros New York

Sage Hill Capital

NGS Super

Canada Pension Plan Investment Board

Next month we’re headed down under – to Perth, Australia for AgriFutures evokeAG 2024. 🇦🇺 
 
Our CEO Ponsi Trivisvavet will join Abi Ramanan, Thijs van Leeuwen, Nicolás Martelli and Nina Schick for the panel discussion, “The Great Balancing Act: AI, the Possibilities, and the Responsibilities.”  
 
We look forward to discussing the nature-positive potential made possible by technology, including how we use AI-powered predictive design to unlock the full potential of seed and deliver step-change products. 
 
See the full program, from Feb 20-21, here: https://lnkd.in/dAwhRVT8  

Wheat is the most important source of carbohydrates in the majority of countries across the globe, so if we’re going to address the critical issue of food security, this all-important crop is a major piece of the puzzle. 
 
As we aim to dramatically increase the yield potential of wheat, we’re fortunate to collaborate with partners like Australia’s InterGrain and Tress Walmsley, who share a vision of transformative change.  
 
It was a pleasure welcoming Tress stateside at our Cambridge, MA office yesterday! Looking forward to the next time we get to connect in person. 

We're ready to hit the ground running in 2024, starting at the 31st Plant and Animal Genome Conference starting this week in sunny San Diego, CA. 
 
If you're attending, don't miss our poster session, as well as Dirk Inze’s Jan. 17 plenary session, “Multiplex Engineering of Yield Traits in Maize," chaired by our own Chief Scientific Officer Catherine Feuillet.
 
See the full program for more information: https://intlpag.org/31/

Metric
Company Name	Inari	CRISPR Biotech Engineering	Innoterra
Symbol
MSH ID	COM:INARI	COM:CRISPR-BTE	COM:INNOTERRA
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Biotechnology	Healthcare & Health Services	Consumer Services
Industry	Agricultural Technology	Biotechnology	Agri-tech
Country	US	GB	IN
Stage	Series		Grant
Employee Count	439
Website	inari.com	crispr-bte.com	innoterra.com
LinkedIn	inariag		innoterra
Founders

Metric
Market Cap	1.80B
Enterprise Value
Monthly Web Traffic	5.53K	1.35K
Web Traffic Growth	0.26	0.72
Valuation
Raised Capital	103M	6.30M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:INARI

Inari

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue